Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial

被引:157
作者
Woelnerhanssen, Bettina [2 ]
Peterli, Ralph [1 ]
Steinert, Robert E. [2 ]
Peters, Thomas [3 ]
Borbely, Yves [1 ]
Beglinger, Christoph [2 ,4 ]
机构
[1] St Clara Hosp, Dept Surg, CH-4016 Basel, Switzerland
[2] Univ Basel Hosp, Dept Biomed, Clin Res Ctr, CH-4031 Basel, Switzerland
[3] St Clara Hosp, Dept Med, CH-4016 Basel, Switzerland
[4] Univ Basel Hosp, Dept Gastroenterol, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Adipokines; Gastric bypass; Sleeve gastrectomy; Bariatric surgery; Incretines; Insulin sensitivity; FIBROBLAST GROWTH FACTOR-21; BODY-FAT DISTRIBUTION; INSULIN SENSITIVITY; BARIATRIC SURGERY; MORBID-OBESITY; BETA-CELL; LEPTIN; ADIPONECTIN; RESISTANCE; GLUCOSE;
D O I
10.1016/j.soard.2011.01.044
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) lead to rapid improvement in insulin sensitivity even before weight loss occurs. Adipokines are closely linked to obesity and insulin resistance. To date, it is unclear whether the different anatomic changes of the various bariatric procedures have different effects on hormones of adipocyte origin. In the present prospective, randomized study, we compared the 1-year follow-up results of LRYGB and LSG concerning weight loss, metabolic control, and fasting adipokine levels. Methods: Of 23 nondiabetic morbidly obese patients, 12 were randomized to LRYGB and 11 to LSG. The patients were investigated before and 1 week, 3 months, and 12 months after surgery. The fasting levels of glucose, insulin, lipids, and adipokines (leptin, adiponectin, and fibroblast growth factor-21) were analyzed. Results: The body weight decreased markedly (P < .001) after either procedure (percentage of weight loss 16.4% +/- 1.3%, 24.8% +/- 1.7%, and 34.5% +/- 2.7% after LRYGB and 13.1% +/- 1.1%, 20.7% +/- 1.5%, and 27.9% +/- 2.6% after LSG at 2, 6, and 12 mo, respectively). The Homeostasis Model Assessment Index declined from 8.0 +/- 1.5 preoperatively to 2.9 +/- .2 at 12 months after LRYGB and from 7.5 +/- 1.7 preoperatively to 3.3 +/- .3 at 12 months after LSG. The lipid profiles were normalized. The concentrations of circulating leptin levels decreased by almost 50% as early as 1 week postoperatively and continued to decrease until 12 months postoperatively. Adiponectin increased progressively. The fibroblast growth factor-21 levels did not change over time. No difference was found between the LRYGB and LSG groups. Conclusion: Both procedures led to significant weight loss associated with the resolution of the metabolic syndrome. The serum leptin levels decreased and adiponectin increased with weight loss, paralleled by improved insulin sensitivity. (Surg Obes Relat Dis 2011;7:561-568.) (C) 2011 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 32 条
  • [1] Suppression of fat deposition for the life time with gene therapy
    Boghossian, S
    Lecklin, A
    Torto, R
    Kalra, PS
    Kalra, SP
    [J]. PEPTIDES, 2005, 26 (08) : 1512 - 1519
  • [2] Hypothalamic clamp on insulin release by leptin-transgene expression
    Boghossian, Stephane
    Dube, Michael G.
    Torto, Rita
    Kalra, Pushpa S.
    Kalra, Satya P.
    [J]. PEPTIDES, 2006, 27 (12) : 3245 - 3254
  • [3] Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
    Chavez, Alberto O.
    Molina-Carrion, Marjorie
    Abdul-Ghani, Muhammad A.
    Folli, Franco
    DeFronzo, Ralph A.
    Tripathy, Devjit
    [J]. DIABETES CARE, 2009, 32 (08) : 1542 - 1546
  • [4] Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
    Cnop, M
    Havel, PJ
    Utzschneider, KM
    Carr, DB
    Sinha, MK
    Boyko, EJ
    Retzlaff, BM
    Knopp, RH
    Brunzell, JD
    Kahn, SE
    [J]. DIABETOLOGIA, 2003, 46 (04) : 459 - 469
  • [5] A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity
    Combs, TP
    Pajvani, UB
    Berg, AH
    Lin, Y
    Jelicks, LA
    Laplante, M
    Nawrocki, AR
    Rajala, MW
    Parlow, AF
    Cheeseboro, L
    Ding, YY
    Russell, RG
    Lindemann, D
    Hartley, A
    Baker, GRC
    Obici, S
    Deshaies, Y
    Ludgate, M
    Rossetti, L
    Scherer, PE
    [J]. ENDOCRINOLOGY, 2004, 145 (01) : 367 - 383
  • [6] Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery
    Cummings, David E.
    Overduin, Joost
    Foster-Schubert, Karen E.
    Carlson, Molly J.
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2007, 3 (02) : 109 - 115
  • [7] Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice?
    Frezza, Eldo E.
    [J]. SURGERY TODAY, 2007, 37 (04) : 275 - 281
  • [8] Leptin and the regulation of body weight in mammals
    Friedman, JM
    Halaas, JL
    [J]. NATURE, 1998, 395 (6704) : 763 - 770
  • [9] The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
    Gaelman, Cecilia
    Lundasen, Tomas
    Kharitonenkov, Alexei
    Bina, Holly A.
    Eriksson, Mats
    Hafstroem, Ingiaeld
    Dahlin, Maria
    Amark, Per
    Angelin, Bo
    Rudling, Mats
    [J]. CELL METABOLISM, 2008, 8 (02) : 169 - 174
  • [10] Garruti G, 2008, J GASTROINTEST LIVER, V17, P193